Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Claris Biotherapeutics logo — Leading the way in corneal therapy

Claris Biotherapeutics

Leading the way in corneal therapy

Founded 2018 United States Jersey City, United States 14 employees Series A Total: $101.50M Biotechnology, Health Care +1

General Information

Company Name Claris Biotherapeutics
Founded Year 2018
Location United States Jersey City, United States
Employees 14
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series A
Business Model B2B, B2B2C
Revenue Model Product Sales, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Claris Biotherapeutics. To contact Claris Biotherapeutics, visit clarisbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Claris Biotherapeutics compare?

A PDF of Claris Biotherapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Claris Biotherapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Claris Biotherapeutics

Claris Bio, founded in 2018 and headquartered in Jersey City, NJ, is pioneering advancements in corneal therapy with its flagship product, CSB-001 Ophthalmic Solution 0.1%. This topical biologic solution, containing the molecule oremepermin-α, is designed to address neurotrophic keratopathy, promising to restore corneal integrity.

The company boasts strong intellectual pedigree, with its foundational research conducted at the renowned Massachusetts Eye and Ear Infirmary by esteemed Harvard Medical School faculty including Dr. Reza Dana and Dr. Sunil Chauhan. Claris operates within the Biotechnology and Health Care sectors, focusing on health and wellness.

Recently, Claris secured a significant $57.00M Series A investment from notable investors like Novo Holdings, RA Capital Management, Janus Henderson, and Mass General Brigham Ventures, underscoring strong confidence in its potential and the innovative space it occupies.

Business keywords: ophthalmology, corneal therapy, biopharma industry, ocular biologic solution, neurotrophic keratopathy, biomedical research, eye health, biopharmaceuticals, intellectual property, start-up, investor analysis, Mass Eye and Ear, Harvard Medical School, biomedical technology, innovation

Services & Products

Topical ocular biologic solutions
Licensing of ophthalmology-related intellectual property
Development and commercialization of corneal therapy products
Drug substance access and development partnerships

Target Customers

Patients with Limbal Stem Cell Deficiency (LSCD) Ophthalmologists and eye care specialists Healthcare providers specializing in corneal therapies Biopharmaceutical companies interested in ophthalmology solutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $57.00M 4
Novo Holdings RA Capital Management Janus Handerson
Novo Holdings, RA Capital Management +2
04 Jan 2024
Venture Round $44.50M -
13 Apr 2020
Venture Round Undisclosed -
01 Jun 2019

Claris Biotherapeutics Alternatives & Competitors

View All Alternatives
Claris Biotherapeutics vs
Pykus Therapeutics
Pykus Therapeutics

Innovative solutions for a smoother, more effective retinal surgery experience

Venture round
10 employees
Health Care, Health and Wellness
Claris Biotherapeutics vs
SightStream Biotherapeutics
SightStream Biotherapeutics United States

Developing unique regenerative & restorative therapies for unmet needs in the ophthalmic space

6 employees
Biotechnology, Health Care
Claris Biotherapeutics vs
ReBio
ReBio Finland

Through The Lens of Progress

Grant
22 employees
Biotechnology, Health Care
View all alternatives

FAQ About Claris Biotherapeutics

Leading the way in corneal therapy
Claris Biotherapeutics was founded in 2018.
Claris Biotherapeutics is headquartered in Jersey City, United States.
Claris Biotherapeutics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on ophthalmology, corneal therapy, biopharma industry and ocular biologic solution. Its customers include Patients with Limbal Stem Cell Deficiency (LSCD), Ophthalmologists and eye care specialists and Healthcare providers specializing in corneal therapies.
Claris Biotherapeutics has a B2B and B2B2C business model. Its revenue comes from Product Sales and Licensing.
Claris Biotherapeutics has approximately 14 employees.
Claris Biotherapeutics has completed 3 funding rounds, raising a total of $101.50M. The latest funding stage is Series A.
Claris Biotherapeutics offers: Topical ocular biologic solutions, Licensing of ophthalmology-related intellectual property, Development and commercialization of corneal therapy products, Drug substance access and development partnerships.
Top alternatives and competitors to Claris Biotherapeutics include Pykus Therapeutics, SightStream Biotherapeutics, ReBio, Histide, osteolabs GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Claris Biotherapeutics and Pykus Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Claris Biotherapeutics, https://bouncewatch.com/company/claris-bio, updated 19 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes